Managing agitation and difficult behavior in dementia.
暂无分享,去创建一个
[1] N. Herrmann,et al. Donepezil for behavioural disorders associated with Lewy bodies: a case series , 2000, International journal of geriatric psychiatry.
[2] J. Edinger,et al. Reversible parkinsonism and cognitive impairment with chronic valproate use , 1996, Neurology.
[3] C. Cooney,et al. Use of drugs by Old Age Psychiatrists in the treatment of psychotic and behavioural symptoms in patients with dementia , 2001, Aging & mental health.
[4] R. Baker,et al. Effectiveness of Rapid Initial Dose Escalation of up to Forty Milligrams per Day of Oral Olanzapine in Acute Agitation , 2003, Journal of clinical psychopharmacology.
[5] A. Schatzberg,et al. Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients. , 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[6] L. Schneider,et al. A Metaanalysis of Controlled Trials of Neuroleptic Treatment in Dementia , 1990, Journal of the American Geriatrics Society.
[7] H. Brodaty,et al. Psychosis, depression and behavioural disturbances in Sydney nursing home residents: prevalence and predictors , 2001, International journal of geriatric psychiatry.
[8] P. Tariot,et al. Treatment of agitation in dementia. , 1997, The Journal of clinical psychiatry.
[9] A. LaCroix,et al. Exercise plus behavioral management in patients with Alzheimer disease: a randomized controlled trial. , 2003, JAMA.
[10] J. Cohen-Mansfield,et al. Assessment of Agitation , 1996, International Psychogeriatrics.
[11] N L Foster,et al. Treatment of agitation in AD , 2000, Neurology.
[12] D. Jeste,et al. Psychosis of Alzheimer's disease and related dementias. Diagnostic criteria for a distinct syndrome. , 2000, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[13] P. Tariot,et al. Efficacy and tolerability of carbamazepine for agitation and aggression in dementia. , 1998, The American journal of psychiatry.
[14] R. Hales,et al. J Neuropsychiatry Clin Neurosci , 1992 .
[15] B. Svarstad,et al. Challenges to the use of nonpharmacologic interventions in nursing homes. , 2002, Psychiatric services.
[16] S. Tunis,et al. Assessing antipsychotic effectiveness in dementia with the factor structure of the Psychogeriatric Dependency Rating Scale (PGDRS). , 2003, Journal of the American Medical Directors Association.
[17] B. Oken. Practice parameter: Management of dementia (an evidence-based review) , 2001, Neurology.
[18] P. Tariot,et al. Mood stabilizers in Alzheimer's disease: symptomatic and neuroprotective rationales. , 2002, Advanced drug delivery reviews.
[19] D. Sultzer,et al. A double-blind comparison of trazodone and haloperidol for treatment of agitation in patients with dementia. , 1997, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[20] A W Toga,et al. Orbital and dorsolateral frontal perfusion defect associated with behavioral response to cholinesterase inhibitor therapy in Alzheimer's disease. , 2000, The Journal of neuropsychiatry and clinical neurosciences.
[21] L. Schneider,et al. Psychosis of Alzheimer disease: validity of the construct and response to risperidone. , 2003, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[22] B. Pollock,et al. Selective Serotonin Reuptake Inhibitors for Late-Life Depression , 2001, Drugs & aging.
[23] D. Jeste,et al. Pharmacological Treatment of Psychosis and Agitation in Elderly Patients with Dementia , 2002 .
[24] C. Wolfson,et al. Factors associated with long-term institutionalization of older people with dementia: data from the Canadian Study of Health and Aging. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.
[25] M. Freedman,et al. Relationship of psychosis to aggression, apathy and function in dementia , 2001, International journal of geriatric psychiatry.
[26] S. McPherson,et al. Neuropsychiatric assessment of Alzheimer’s disease and related dementias , 2001, Aging.
[27] G A Chase,et al. Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease. , 1990, The American journal of psychiatry.
[28] D. Aarsland,et al. Cognitive, psychiatric and motor response to galantamine in Parkinson's disease with dementia , 2003, International journal of geriatric psychiatry.
[29] L. Miller. Gabapentin for Treatment of Behavioral and Psychological Symptoms of Dementia , 2001, The Annals of pharmacotherapy.
[30] H. Sackeim,et al. A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease. , 1998, The American journal of psychiatry.
[31] M. Raji,et al. Mirtazapine for Treatment of Depression and Comorbidities in Alzheimer Disease , 2001, The Annals of pharmacotherapy.
[32] R. Petersen,et al. A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer's disease. , 2003, The American journal of psychiatry.
[33] Kristine Yaffe,et al. Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis. , 2003, JAMA.
[34] S H Ferris,et al. A family intervention to delay nursing home placement of patients with Alzheimer disease. A randomized controlled trial. , 1996, JAMA.
[35] J. Yesavage,et al. How Well Are Clinicians Following Dementia Practice Guidelines? , 2002, Alzheimer disease and associated disorders.
[36] P. Tariot,et al. Valproate therapy for agitation in dementia: open-label extension of a double-blind trial. , 2003, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[37] G. Grossberg. The ABC of Alzheimer's Disease: Behavioral Symptoms and Their Treatment , 2002, International Psychogeriatrics.
[38] M. Mega,et al. The Neuropsychiatric Inventory , 1994, Neurology.
[39] A. C. Stein,et al. Practice parameter: Risk of driving and Alzheimer’s disease (an evidence-based review) , 2000, Neurology.
[40] Charles M Beasley,et al. Comparison of Rapidly Acting Intramuscular Olanzapine, Lorazepam, and Placebo: A Double-blind, Randomized Study in Acutely Agitated Patients with Dementia , 2002, Neuropsychopharmacology.
[41] D. Christensen,et al. Alprazolam as an Alternative to Low‐Dose Haloperidol in Older, Cognitively Impaired Nursing Facility Patients , 1998, Journal of the American Geriatrics Society.
[42] C. Salzman. Treatment of the agitation of late-life psychosis and Alzheimer’s disease , 2001, European Psychiatry.
[43] J. Friedman,et al. Long‐term outcome of quetiapine use for psychosis among parkinsonian patients , 2003, Movement disorders : official journal of the Movement Disorder Society.
[44] S. Edland,et al. Prevalence and incidence of major depression in Alzheimer's disease. , 1994, The American journal of psychiatry.
[45] D. Sultzer,et al. Does Behavioral Improvement with Haloperidol or Trazodone Treatment Depend on Psychosis or Mood Symptoms in Patients with Dementia? , 2001, Journal of the American Geriatrics Society.
[46] Jacob Gordon,et al. Clozapine in Parkinson's Disease Psychosis: 5-Year Follow-up Review , 2003, Clinical neuropharmacology.
[47] H. Khouzam. Capgras syndrome responding to the antidepressant mirtazapine , 2002, Comprehensive therapy.
[48] D. Jeste,et al. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group. , 1999, The Journal of clinical psychiatry.
[49] O. Zanetti,et al. Memory rehabilitation in Alzheimer's disease: a review of progress , 2001, International journal of geriatric psychiatry.
[50] R. Tamura,et al. Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group. , 2000, Archives of general psychiatry.
[51] N. Herrmann. Recommendations for the Management of Behavioral and Psychological Symptoms of Dementia , 2001, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[52] J. Yesavage,et al. A retrospective chart review of gabapentin for the treatment of aggressive and agitated behavior in patients with dementias. , 2000, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[53] R. van Reekum,et al. Gender, aggression and serotonergic function are associated with response to sertraline for behavioral disturbances in Alzheimer's disease , 2002, International journal of geriatric psychiatry.
[54] J. Cohen-Mansfield,et al. A description of agitation in a nursing home. , 1989, Journal of gerontology.
[55] V. Lerner,et al. Donepezil as Add-on Treatment of Psychotic Symptoms in Patients with Dementia of the Alzheimer's Type , 2003, Clinical neuropharmacology.
[56] G. Miremont-Salamé,et al. Benzodiazepine utilization patterns in Alzheimer's disease patients , 2003, Pharmacoepidemiology and drug safety.
[57] S H Ferris,et al. Assessing Patterns of Agitation in Alzheimer's Disease Patients with the Cohen‐Mansfield Agitation Inventory , 1997, Alzheimer disease and associated disorders.
[58] S. Finkel,et al. Behavioral and psychological symptoms of dementia: a current focus for clinicians, researchers, and caregivers. , 2001, The Journal of clinical psychiatry.
[59] M. Denke,et al. Intramuscular medroxyprogesterone acetate for sexual aggression in elderly men , 1992, The Lancet.
[60] B. Pollock,et al. Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients. , 2002, The American journal of psychiatry.
[61] L. Thal,et al. No Long-Term Effect of Behavioral Treatment on Psychotropic Drug Use for Agitation in Alzheimer's Disease Patients , 2002, Journal of geriatric psychiatry and neurology.
[62] P. Roy-Byrne,et al. Assessment and Treatment of Nursing Home Residents with Depression or Behavioral Symptoms Associated with Dementia: A Review of the Literature , 2003, Journal of the American Geriatrics Society.
[63] D. Paleacu,et al. Donepezil for the Treatment of Behavioral Symptoms in Patients With Alzheimer's Disease , 2002, Clinical neuropharmacology.
[64] D. Scharre,et al. Cognitive and Behavioral Effects of Quetiapine in Alzheimer Disease Patients , 2002, Alzheimer disease and associated disorders.
[65] M. Mega,et al. The spectrum of behavioral responses to cholinesterase inhibitor therapy in Alzheimer disease. , 1999, Archives of neurology.
[66] M. Weiner,et al. Balancing psychosocial and psychopharmacologic measures in Alzheimer's disease , 1994 .
[67] Cooper Aj. Medroxyprogesterone acetate (MPA) treatment of sexual acting out in men suffering from dementia. , 1987 .
[68] H. Higuchi,et al. Quetiapine treatment of psychotic symptoms and aggressive behavior in patients with dementia with Lewy bodies: A case series , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[69] R. Reeves,et al. Orally disintegrating olanzapine for the treatment of psychotic and behavioral disturbances associated with dementia. , 2003, Southern medical journal.
[70] Jeffrey L. Cummings,et al. Practice parameter: Diagnosis of dementia (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology , 2001 .
[71] B. Vaccaro,et al. Clozapine in Older Patients With Psychosis and Behavioral Disruption. , 1995, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.